Status:
COMPLETED
Dual Task Training On Children With Ataxia After Medulloblastoma Resection
Lead Sponsor:
Children's Cancer Hospital Egypt 57357
Conditions:
Medulloblastoma, Childhood
Childhood Cancer
Eligibility:
All Genders
5-10 years
Phase:
NA
Brief Summary
Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. With the goal of,...
Detailed Description
Most patients present with symptoms of hydrocephalus due to obstruction by tumor at the level of the fourth ventricle or cerebral aqueduct, and ataxia (Martin et al., 2014). If the tumor is large enou...
Eligibility Criteria
Inclusion
- Age range from (5-10 years).
- Severity of ataxia will be from 15-30 by SARA scale.
- Children after 2 months of medulloblastoma resection.
- They can stand and walk with minimal support.
- They have good cognition, compliance, and ability to understand and execute test instructions.
- Children receiving radiotherapy and chemotherapy sessions
- They are medically stable
Exclusion
- Children will be excluded from the study if they have
- Any neuromuscular disorder.
- Visual impairment.
- Cognitive problem
- Convulsion.
- Peripheral neuropathy due to chemotherapy.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04860934
Start Date
March 15 2021
End Date
November 30 2021
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Cancer Hospital Egypt 57357
Cairo, Egypt, 11441